WhitTier Trust Company’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.67M Sell
69,206
-15,728
-19% -$411K 0.03% 242
2026
Q1
$2.36M Sell
84,934
-2,242
-3% -$59.7K 0.05% 216
2025
Q4
$2.22M Sell
87,176
-12,173
-12% -$307K 0.05% 223
2025
Q3
$2.72M Sell
99,349
-7,122
-7% -$176K 0.06% 202
2025
Q2
$2.58M Sell
106,471
-8,886
-8% -$207K 0.06% 219
2025
Q1
$2.92M Sell
115,357
-8,263
-7% -$216K 0.07% 205
2024
Q4
$3.28M Sell
123,620
-5,507
-4% -$149K 0.08% 190
2024
Q3
$3.74M Sell
129,127
-19,458
-13% -$568K 0.1% 169
2024
Q2
$4.16M Sell
148,585
-112,406
-43% -$3.09M 0.12% 152
2024
Q1
$7.24M Sell
260,991
-7,762
-3% -$215K 0.21% 106
2023
Q4
$7.74M Sell
268,753
-3,271
-1% -$98.9K 0.25% 97
2023
Q3
$9.02M Buy
272,024
+1,147
+0.4% +$40.6K 0.32% 75
2023
Q2
$9.94M Sell
270,877
-1,726
-0.6% -$67.2K 0.34% 71
2023
Q1
$11.1M Buy
272,603
+933
+0.3% +$40.3K 0.41% 61
2022
Q4
$13.9M Buy
271,670
+120
+0% +$5.75K 0.55% 45
2022
Q3
$11.9M Buy
271,550
+1,366
+0.5% +$66.4K 0.51% 46
2022
Q2
$14.2M Buy
270,184
+5,620
+2% +$286K 0.58% 40
2022
Q1
$13.7M Buy
264,564
+19,024
+8% +$987K 0.5% 44
2021
Q4
$14.5M Buy
245,540
+5,879
+2% +$291K 0.53% 45
2021
Q3
$10.3M Buy
239,661
+1,718
+0.7% +$76.1K 0.42% 56
2021
Q2
$9.31M Sell
237,943
-4,572
-2% -$178K 0.39% 64
2021
Q1
$8.78M Buy
242,515
+1,286
+0.5% +$45.7K 0.39% 62
2020
Q4
$8.88M Sell
241,229
-10,614
-4% -$389K 0.44% 54
2020
Q3
$8.77M Buy
251,843
+3,073
+1% +$108K 0.51% 52
2020
Q2
$7.72M Sell
248,770
-12,752
-5% -$433K 0.49% 51
2020
Q1
$8.1M Buy
261,522
+1,114
+0.4% +$38K 0.62% 37
2019
Q4
$9.68M Sell
260,408
-25,985
-9% -$926K 0.62% 42
2019
Q3
$9.76M Buy
286,393
+1,171
+0.4% +$42.6K 0.68% 38
2019
Q2
$11.7M Sell
285,222
-23,806
-8% -$945K 0.83% 30
2019
Q1
$12.5M Sell
309,028
-22,615
-7% -$906K 0.92% 28
2018
Q4
$13.7M Sell
331,643
-490
-0.1% -$20.3K 1.13% 22
2018
Q3
$13.9M Buy
332,133
+613
+0.2% +$23.6K 1.01% 24
2018
Q2
$11.4M Buy
331,520
+3,795
+1% +$130K 0.89% 26
2018
Q1
$11M Sell
327,725
-9,923
-3% -$341K 0.9% 26
2017
Q4
$11.6M Buy
337,648
+22,548
+7% +$769K 0.99% 23
2017
Q3
$10.7M Buy
315,100
+1,937
+0.6% +$62.3K 0.99% 24
2017
Q2
$9.98M Buy
313,163
+6,565
+2% +$207K 0.97% 23
2017
Q1
$9.95M Buy
306,598
+64
+0% +$2.02K 0.99% 20
2016
Q4
$9.44M Buy
306,534
+8,868
+3% +$271K 1% 22
2016
Q3
$9.56M Buy
297,666
+3,084
+1% +$103K 1.09% 19
2016
Q2
$9.84M Buy
294,582
+3,217
+1% +$103K 1.12% 18
2016
Q1
$8.19M Buy
291,365
+1,904
+0.7% +$54.4K 0.96% 20
2015
Q4
$8.86M Buy
289,461
+7,108
+3% +$224K 1.04% 19
2015
Q3
$8.41M Sell
282,353
-15,523
-5% -$498K 1.03% 21
2015
Q2
$9.47M Buy
297,876
+4,136
+1% +$135K 1.05% 21
2015
Q1
$9.7M Buy
293,740
+2,343
+0.8% +$74.5K 1.07% 20
2014
Q4
$8.61M Buy
291,397
+4,196
+1% +$120K 0.96% 23
2014
Q3
$8.05M Buy
287,201
+303
+0.1% +$8.5K 0.93% 24
2014
Q2
$8.08M Buy
286,898
+2,788
+1% +$79.5K 0.91% 25
2014
Q1
$8.65M Buy
284,110
+6,344
+2% +$189K 1.01% 20
2013
Q4
$8.07M Buy
277,766
+25,906
+10% +$754K 0.97% 21
2013
Q3
$6.86M Buy
251,860
+7,269
+3% +$198K 0.92% 24
2013
Q2
$6.5M Buy
+244,591
New +$6.76M 0.94% 24

Other funds holding PFE

WhitTier Trust Company's PFE Position: Q2 2026 in Review

WhitTier Trust Company reduced its Pfizer (PFE) stake by 19% in Q2 2026, selling an estimated $411K and leaving 69,206 shares worth $1.67M. The position accounts for 0.03% of the portfolio, ranked #242.

WhitTier Trust Company first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $14.5M in Q4 2021. 1,247 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • WhitTier Trust Company held 69,206 shares of Pfizer worth $1.67M as of Q2 2026.
  • WhitTier Trust Company sold 15,728 Pfizer shares in Q2 2026, an estimated $411K.
  • Pfizer made up 0.03% of WhitTier Trust Company's portfolio in Q2 2026, its #242 holding.
  • WhitTier Trust Company first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • WhitTier Trust Company's Pfizer position peaked at $14.5M in Q4 2021.
  • 1,247 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.